Table 1 Details of laboratory tests before, during, and after treatment
Alb | Scr | Globulin | Hb | IgA | Monoclonal | Gamma | Proteinuria | BM plasma | |
|---|---|---|---|---|---|---|---|---|---|
(g/l) | (μmol/l) | (g/l) | (g/l) | (g/l) | Ig | globulin (%) | (g/24 h) | cell (%) | |
Before treatment | 19.6 | 54.6 | 24.2 | 86 | 8.66 | IgA κ | 6 | 15 | 3 |
1st BCD*4 | 20 | 74.1 | 22.5 | 118 | 4.21 | IgA κ | 11.7 | 13.3 | 1.5 |
2nd BCD*4 | 21.5 | 50.1 | 15.4 | 95 | 2.13 | IgA κ | – | 4.68 | – |
3rd BCD*4 | 25.1 | 62.8 | 19.8 | 104 | 1.92 | – | 9.9 | 8.9 | 0.5 |
4th BCD*4 | 23.8 | 61.2 | 17.7 | 83 | 1.25 | IgA κ | 9 | 12 | 1 |
5th BCD*4 | 23 | 51.8 | 15.2 | 94 | 0.86 | IgA κ | 7.7 | 6.95 | 1 |
6th BCD*4 | 27.5 | 54 | 17.5 | 105 | 0.77 | Neg | 9.1 | 9.32 | – |
7th BCD*4 | 24.6 | 39.2 | 16 | 99 | 0.64 | Neg | 8.6 | 6.25 | – |
1st and 2nd BD | 34.3 | 54.7 | 20.4 | 113 | 0.82 | Neg | 8.9 | 4.176 | – |
3rd BD | 31 | 60.8 | 18.4 | 96 | 0.17 | Neg | 9.7 | 4.8 | – |
4th BD | 33.5 | 74.1 | 18.6 | 99 | – | Neg | 10.6 | 5.238 | – |
5th BD | 36.5 | 72.2 | 21 | 101 | – | – | 10 | – | – |
6th BD | 40.8 | 81 | 18 | 106 | 0.72 | – | – | 1.82 | 1 |
3 months after last BD | 33.1 | 68.7 | 18.9 | 109 | 0.8 | Neg | 8.9 | 3.21 | – |
7 months after last BD | 41.8 | 76.4 | 21.3 | 128 | 1.2 | Neg | 11.6 | 4.03 | – |
14 months after last BD | 37.96 | 81.15 | 17.68 | 104 | 1.06 | – | 10.5 | 2.49 | – |
17 months after last BD | 40.8 | 102.8 | 23.7 | 99 | 1.19 | Neg | 12.3 | 1.54 | – |